FDA recall D-0128-2019

Boehringer Ingelheim Pharmaceuticals, Inc. · Class II · drug

Product

Catapres .2 (clonidine hydrochloride, USP) 0.2mg, 100-count bottles, Rx only, Dist. by: Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT 06877 USA. Made in Germany. NDC 0597-0007-01

Reason for recall

Failed Dissolution Specifications: OOS resultsduring routine stability testing

Distribution

Distributed nationwide in the USA and Puerto Rico

Key facts

Status
Terminated
Initiation date
2018-10-22
Report date
2018-11-07
Termination date
2023-04-03
Voluntary/Mandated
Voluntary: Firm initiated
Location
Ridgefield, CT, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0128-2019